20 results
8-K
EX-10.1
ADPT
Adaptive Biotechnologies Corp
12 Sep 22
Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million
8:45am
to Products, (c) all Regulatory Approvals related to Products, (d) all inventory of Products and any raw materials and work-in-process relating thereto, (e
10-K
m4oxkxoozj1x pkj04
26 Feb 20
Annual report
4:53pm
424B4
hvouf
24 Jan 20
Prospectus supplement with pricing info
4:49pm
DRS
paqtrih50de3lf w8njh
9 Jan 20
Draft registration statement
12:00am
424B4
2a4ky1vhzsw5
27 Jun 19
Prospectus supplement with pricing info
5:24pm
S-1
vja6rvl2nouw
30 May 19
IPO registration
5:20pm
DRS/A
6mkzvw6uy8
8 May 19
Draft registration statement (amended)
12:00am
DRS
tbhoeqlkwmjnt
29 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next